Antithyroid drugs in Graves′ disease: Are we stretching it too far?
Introduction: Early and durable achievement of euthyroid or hypothyroid status with low likelihood of relapse is the key to effective treatment of Graves′ disease (GD). Although antithyroid drugs (ATDs) are commonly used first-line agents, likelihood of remission remains highest with radioactive iod...
Main Authors: | Muthukrishnan Jayaraman, Anil Kumar Pawah, C S Narayanan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2016;volume=20;issue=5;spage=600;epage=604;aulast=Jayaraman |
Similar Items
-
Indefinite antithyroid drug therapy in toxic Graves′ disease: What are the cons
by: Rajesh Rajput, et al.
Published: (2013-01-01) -
Changes in the Ocular Parameters of Patients with Graves’ Disease after Antithyroid Drug Treatment
by: Jesang Lee, et al.
Published: (2021-04-01) -
Hyperthyroidism in Pregnancy: The Delicate Balance between Too Much or Too Little Antithyroid Drug
by: Monica Livia Gheorghiu, et al.
Published: (2021-08-01) -
The role of long term use of antithyroid drugs in Graves’ disease
by: SA Abhayaratna, et al.
Published: (2013-05-01) -
Antithyroid Drug Treatment in Graves’ Disease
by: Jae Hoon Chung
Published: (2021-06-01)